Publication: Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))
| cris.lastimport.scopus | 2025-05-08T22:16:57Z | |
| cris.virtual.department | Clinical Medicine | |
| cris.virtual.department | Internal Medicine-NTUH | |
| cris.virtual.orcid | 0000-0001-8316-3785 | en_US |
| cris.virtualsource.department | 5140de8d-4c03-401a-8973-f4eef91d7932 | |
| cris.virtualsource.department | 5140de8d-4c03-401a-8973-f4eef91d7932 | |
| cris.virtualsource.orcid | 5140de8d-4c03-401a-8973-f4eef91d7932 | |
| dc.contributor.author | Chen K.-F. | en_US |
| dc.contributor.author | Tai W.-T. | en_US |
| dc.contributor.author | Hsu C.-Y. | en_US |
| dc.contributor.author | Huang J.-W. | en_US |
| dc.contributor.author | Liu C.-Y. | en_US |
| dc.contributor.author | PEI-JER CHEN | en_US |
| dc.contributor.author | Kim I. | en_US |
| dc.contributor.author | Shiau C.-W. | en_US |
| dc.date.accessioned | 2021-07-03T03:33:42Z | |
| dc.date.available | 2021-07-03T03:33:42Z | |
| dc.date.issued | 2018 | |
| dc.identifier.doi | 10.1016/j.ejmech.2017.10.053 | |
| dc.identifier.issn | 0223-5234 | |
| dc.identifier.pmid | 29113744 | |
| dc.identifier.scopus | 2-s2.0-85032826314 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032826314&doi=10.1016%2fj.ejmech.2017.10.053&partnerID=40&md5=cc9053f5bd0e2937b2761feb70ea1d7d | |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/568353 | |
| dc.publisher | Elsevier Masson SAS | |
| dc.relation.ispartof | European Journal of Medicinal Chemistry | |
| dc.relation.journalvolume | 143 | |
| dc.title | Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) | |
| dc.type | corrigendum | |
| dspace.entity.type | Publication |